LIPOSARCOMA
Clinical trials for LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new LIPOSARCOMA trials appear
Sign up with your email to follow new studies for LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells target tough childhood cancers
Disease control OngoingThis early-phase study is testing a new type of cell therapy called AGAR T cells in children and young adults with solid tumors that have come back or haven't responded to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to better recognize and…
Matched conditions: LIPOSARCOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Virus therapy teams up with radiation to fight sarcoma
Disease control OngoingThis study is testing a two-part treatment for soft tissue sarcoma that can be removed by surgery. First, doctors inject a modified cold sore virus (T-VEC) directly into the tumor to help the immune system attack the cancer. Then, patients receive a standard course of radiation t…
Matched conditions: LIPOSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New cancer drug combo enters key testing phase
Disease control OngoingThis study is testing a new drug, PF-07220060, to see if it is safe and can help control advanced cancers. It will be given alone and in combination with other standard hormone therapies. The trial is for people with certain advanced solid tumors, including breast, prostate, and …
Matched conditions: LIPOSARCOMA
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New combo attack on rare abdominal cancer before surgery
Disease control OngoingThis early-stage study is testing the safety and best dose of a chemotherapy drug called eribulin when given with radiation therapy before surgery. It involves 15 patients with a rare abdominal cancer called retroperitoneal liposarcoma. The goal is to see if this combined approac…
Matched conditions: LIPOSARCOMA
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for tough sarcomas: adding a targeted drug to standard treatment
Disease control OngoingThis study is for patients with newly diagnosed, high-risk soft tissue sarcomas that can be removed by surgery. It tests whether adding a drug called pazopanib to standard pre-surgery treatments (radiation with or without chemotherapy) helps shrink tumors more effectively and imp…
Matched conditions: LIPOSARCOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Scientists test supercharged immune cells to attack tough cancers
Disease control OngoingThis early-stage study is testing a new type of treatment called CATCH T cells in adults with advanced solid tumors that have a specific marker (GPC3). Doctors take a patient's own immune cells, genetically modify them in a lab to better recognize and attack cancer, and then infu…
Matched conditions: LIPOSARCOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC